The correlation of cardiac and hepatic hemosiderosis as measured by T2*MRI technique with ferritin levels and hemochromatosis gene mutations in Iranian patients with beta thalassemia major

Abstract EN

Objectives: Organ-specific hemosiderosis and iron overload complications are more serious and more frequent in some patients with beta thalassemia major (BTM) compared with others.

We investigated whether coinheritance of HFE H63D or C282Y gene mutations in patients with BTM contributes to the phenotypic variation of iron overload complications and assessed the correlation of cardiac and hepatic hemosiderosis with plasma ferritin levels.

Methods: We studied 60 patients with BTM with a mean age of 17.5±9.1 years from the Northwest of Iran.

HFE gene mutations were analyzed using the polymerase chain reaction-restriction fragment length polymorphism method.

Cardiac and hepatic hemosiderosis was assessed using T2*magnetic resonance imaging (MR I).

Ferritin levels were measured using the enzyme immunoassay method.

Results: Ferritin levels showed a strong inverse correlation with hepatic T2*MR I values (r = -0.631, p = 0.001) but a poor correlation with cardiac T2*MR I values (r = -0.297, p = 0.044).

The correlation between cardiac T2*MR I values and hepatic T2*MR I values was poor and insignificant (r = 0.287, p = 0.058).

Genotype and allele distribution of HFE H63D and C282Y mutation did not differ significantly between patients with and without hepatic or cardiac hemosiderosis (p > 0.050).

However, carriers of HFE 63D allele had significantly higher ferritin levels compared with non-carriers (1 903±993 vs.

992±683, p < 0.001).

Conclusions: Cardiac T2*MR I values showed a poor correlation with hepatic T2*MR I values and ferritin levels.

Accurate assessment of cardiac iron overload in patients with BTM can only be done using the T2*MR I technique.

Additionally, HFE H63D is a significant determinant factor for elevated ferritin levels in BTM patients